Back to PATH Stock Lookup

UiPath Inc. (PATH) – Management Comments

Jun 8, 2021 04:12 PM UiPath Inc. (PATH) Reports Q1 EPS of $0.02 on Revenues of $186.2M; Offers 2Q Revenues Outlook
Jan 21, 2014 07:04 AM Teva Pharma (TEVA) to Acquire NuPathe for $3.65/Share + Rights
Dec 19, 2013 08:19 AM
Dec 16, 2013 07:06 AM

Back to PATH Stock Lookup